These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 30387820)
1. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice. Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice. Dong JP; Zheng Y; Wu T; He Q; Teng GG; Wang HH Chin Med J (Engl); 2019 Aug; 132(16):1951-1958. PubMed ID: 31335471 [TBL] [Abstract][Full Text] [Related]
3. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota. Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526 [TBL] [Abstract][Full Text] [Related]
4. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870 [TBL] [Abstract][Full Text] [Related]
5. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. Chen X; Yang G; Song JH; Xu H; Li D; Goldsmith J; Zeng H; Parsons-Wingerter PA; Reinecker HC; Kelly CP PLoS One; 2013; 8(5):e64227. PubMed ID: 23675530 [TBL] [Abstract][Full Text] [Related]
6. Both Xu X; Wu J; Jin Y; Huang K; Zhang Y; Liang Z Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986214 [TBL] [Abstract][Full Text] [Related]
7. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide. Liu CH; Chang JH; Chang YC; Mou KY J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105 [TBL] [Abstract][Full Text] [Related]
8. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Jawhara S; Poulain D Med Mycol; 2007 Dec; 45(8):691-700. PubMed ID: 17885943 [TBL] [Abstract][Full Text] [Related]
9. Gao H; Li Y; Sun J; Xu H; Wang M; Zuo X; Fu Q; Guo Y; Chen Z; Zhang P; Li X; Wang N; Ye T; Yao Y Oxid Med Cell Longev; 2021; 2021():1622375. PubMed ID: 34367460 [No Abstract] [Full Text] [Related]
10. Li B; Zhang H; Shi L; Li R; Luo Y; Deng Y; Li S; Li R; Liu Z Food Funct; 2022 Jan; 13(1):102-112. PubMed ID: 34878454 [TBL] [Abstract][Full Text] [Related]
11. [Effect of VSL#3 and Meng XC; Wang YN; Yan PG; Li YH; Wang HY; Qian JM; Li JN Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1735-1742. PubMed ID: 31216822 [No Abstract] [Full Text] [Related]
13. The Probiotic Effects of the Lee JE; Lee E J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078 [TBL] [Abstract][Full Text] [Related]
14. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473 [TBL] [Abstract][Full Text] [Related]
15. A Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor. Qin X; Zhao Q; Zhao Q; Yang L; Li W; Wu J; Liu T; Zhong W; Jiang K; Liu W; Wang B; Wang S; Cao H Pharmacol Res; 2024 Oct; 208():107372. PubMed ID: 39182661 [TBL] [Abstract][Full Text] [Related]
16. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Xue X; Ramakrishnan S; Anderson E; Taylor M; Zimmermann EM; Spence JR; Huang S; Greenson JK; Shah YM Gastroenterology; 2013 Oct; 145(4):831-41. PubMed ID: 23860500 [TBL] [Abstract][Full Text] [Related]
17. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii. Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208 [TBL] [Abstract][Full Text] [Related]
18. A comparative evaluation of the kefir yeast Youn HY; Kim HJ; Kim H; Seo KH Food Funct; 2024 Jun; 15(12):6717-6730. PubMed ID: 38833212 [TBL] [Abstract][Full Text] [Related]